• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Symetis sets range for $96m IPO

Symetis sets range for $96m IPO

September 15, 2015 By MassDevice

Symetis(Reuters) — Symetis, a Swiss maker of replacement heart valve devices, said it has set a price range for its initial sale of shares between 35 and 46 Swiss francs ($36.16-$47.53), as it seeks to raise money from investors for business expansion and R&D. At the midpoint the flotation would fetch CHF 93.2 million ($96.2 million).

Symetis is offering up to 2.3 million new shares and has said it aims to raise 80 million francs.

The price range of the shares, due to begin trading Sept. 29, implies a total market value of between CHF 200 million and 240 million ($206.7 million to $248.0 million), the company said.

The Lausanne-based company has said the money raised by the Swiss listing would allow it to expand its business in the European Union and boost research and development efforts and clinical trials in Japan and the U.S.

Existing Symetis investors have pledged to buy shares worth up to CHF 15 million ($15.5 million) and are due to be granted a preferential allocation.

Symetis, its board and executive managers have committed to a lock-up period of 12 months, while others including employees, former employees and consultants and creditors have committed to a lock-up period of 6 months.

The valve maker has said it had CHF 10.8 million ($11.2 million) in revenue for the 1st half of 2015, up 68% from the same period a year earlier after stripping out the impact of currency changes.

Symetis’ 1st 2 products, Acurate TA and Acurate neo/TF, were launched in Germany, Austria and Switzerland and sales were recently expanded into other European countries.

When it announced the IPO earlier this year, Symetis said Credit Suisse was the global coordinator and joint bookrunner, with Jefferies International also a bookrunner. Bank am Bellevue AG and Bank Vontobel AG are co-managers.

($1 = 0.9678 Swiss francs)

Filed Under: Funding Roundup, Initial Public Offering (IPO), Replacement Heart Valves Tagged With: Symetis

More recent news

  • Philips prices $1.1B offering to pay off debt, finance green projects
  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech
  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy
  • Elucent Medical wins FDA breakthrough nod for in-body spatial intelligence system
  • EndoQuest Robotics completes first cases in pivotal surgical robot trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy